Literature DB >> 30283821

AP4S1 splice-site mutation in a case of spastic paraplegia type 52 with polymicrogyria.

Susana Carmona1, Clara Marecos1, Marta Amorim1, Ana C Ferreira1, Carla Conceição1, José Brás1, Sofia T Duarte1, Rita Guerreiro1.   

Abstract

Entities:  

Year:  2018        PMID: 30283821      PMCID: PMC6167175          DOI: 10.1212/NXG.0000000000000273

Source DB:  PubMed          Journal:  Neurol Genet        ISSN: 2376-7839


× No keyword cloud information.
Hereditary spastic paraplegias (HSPs) are a group of rare inherited neurodegenerative disorders that result from primary retrograde dysfunction of the long descending fibers of the corticospinal tract, causing lower limb spasticity and muscular weakness. This group of diseases has a heterogeneous clinical presentation. An extensive list of associated genes, different inheritance patterns, and ages at onset have been reported in HSPs.[1] Spastic paraplegia type 52 (SPG52) is an autosomal recessive disease caused by AP4S1 mutations. The disease is characterized by neonatal hypotonia that progresses to hypertonia and spasticity in early childhood, developmental delay, mental retardation, and poor or absent speech. Febrile or afebrile seizures may also occur.[2-4]

Clinical case presentation

We report the case of a Portuguese 2-year-old boy born to healthy nonconsanguineous parents after a full-term gestation with intrauterine growth restriction after week 37. During the first months of life, the patient presented poor weight gain, hyperammonemia with elevation of glutamine and ornithine, low citrulline, and negative orotic acid. Weight recovery and normalization of amino acid profile were observed after protein restriction and remained normal after reintroduction of normal diet. Genetic study of urea cycle disorders (NAGS, CPS, and OTC) was negative. Around 9 months of age, global developmental delay, hypotonia, and strabismus were evident. Brain MRI with spectroscopy (performed at 10 months) showed delayed myelination/hypomyelination associated with a posterior perisylvian polymicrogyria, thinning of the corpus callosum, dilation and dysmorphia of the ventricles, and enlargement of the subarachnoid frontotemporal space (figure A). Spectroscopy suggested a possible discrete reduction of N-acetylaspartate. EEG showed a slight intermittent lentification in the left temporal region. At 15 months of age, the patient had 1 afebrile episode of status epilepticus. Two previous shorter episodes with fever had also occurred. Levetiracetam was started. No regression of psychomotor development after seizure was observed, and the patient has been evolving gradually with improvement of axial hypotonia. He says a few simple words, responds to his name, and has some nonverbal communication. The most recent neurologic evaluation revealed an alteration of the muscle tone (hypertonia) in the left lower limb and pyramidal signs in both legs.
Figure

Patient's brain imaging, pedigree, and consequences of AP4S1 c.294+1G>T variant

(A) Left image: sagittal T1 weighted image showing thin corpus callosum. Central and right images: axial T2 weighted images showing delayed myelination, bilateral posterior perisylvian polymicrogyria, dysmorphic and enlarged ventricles, and enlargement of subarachnoid space. (B) Family pedigree. The proband presents the splice-site variant chr14:g.31542180G>T NM_001128126.2:c.294+1G>T in the homozygous state, and both parents are heterozygous for the variant. +: c.294+1G>T allele; −: wild-type allele. (C) AP4S1 transcript size of the homozygous patient, both heterozygous parents, and the wild-type individual. A shorter transcript is produced in the presence of the variant. Each band of the marker ladder represents 100 bp (band size from gel bottom to top: 100, 200, 300, 400, 500, 600, 700, 800, 900, and 1000 bp). (D) Alignment of the wild-type protein sequence (NP_001121598) to the mutated protein. The alignment was performed with Clustal Omega. The variant leads to the loss of amino acids 76–98. C− = negative control; F = father; M = marker ladder; Mo = mother; mut = mutated protein; P = patient; WT = wild-type.

Patient's brain imaging, pedigree, and consequences of AP4S1 c.294+1G>T variant

(A) Left image: sagittal T1 weighted image showing thin corpus callosum. Central and right images: axial T2 weighted images showing delayed myelination, bilateral posterior perisylvian polymicrogyria, dysmorphic and enlarged ventricles, and enlargement of subarachnoid space. (B) Family pedigree. The proband presents the splice-site variant chr14:g.31542180G>T NM_001128126.2:c.294+1G>T in the homozygous state, and both parents are heterozygous for the variant. +: c.294+1G>T allele; −: wild-type allele. (C) AP4S1 transcript size of the homozygous patient, both heterozygous parents, and the wild-type individual. A shorter transcript is produced in the presence of the variant. Each band of the marker ladder represents 100 bp (band size from gel bottom to top: 100, 200, 300, 400, 500, 600, 700, 800, 900, and 1000 bp). (D) Alignment of the wild-type protein sequence (NP_001121598) to the mutated protein. The alignment was performed with Clustal Omega. The variant leads to the loss of amino acids 76–98. C− = negative control; F = father; M = marker ladder; Mo = mother; mut = mutated protein; P = patient; WT = wild-type. Exome sequencing of the proband and parents was performed as described in Supplementary Material (links.lww.com/NXG/A86) and revealed the homozygous AP4S1 splice site NM_001128126.2:c.294+1G>T r.619_687del variant in the proband, present in the heterozygous state in the parents (figure B). The variant was located in a 2.4-Mb homozygous region of chromosome 14. This variant is extremely rare in the population, with only 1 heterozygous individual present in the Genome Aggregation Database. In silico analysis predicted the loss of the donor splice site of exon 4. A transcript size analysis and Sanger sequencing of cDNA confirmed the presence of a shorter transcript skipping exon 4 associated with the variant (figure C). As a consequence, the polypeptide of 23 amino acids (76 a.a.–98 a.a.) encoded by exon 4 is lost (figure D).

Discussion

AP4S1 encodes the small subunit of the adaptor protein complex-4 (AP4 complex). This complex is recruited to the trans-Golgi network, where it mediates vesicle trafficking to endosomes or basolateral plasma membrane in a clathrin-independent manner.[5] Mutations in the 4 subunits of the complex have been associated with similar autosomal recessive phenotypes mainly characterized by spastic tetraplegia.[6] The mutation found in our patient leads to the loss of exon 4, with predicted important consequences to the protein structure and the AP4 complex function. Anatomical changes similar to those observed in patients have been reported in an AP-4 complex knockout mouse model: enlargement of the lateral ventricles and thinning of the corpus callosum.[7] Similar changes have also been seen in the patient described here, together with febrile and afebrile seizures. When exome sequencing was performed and analyzed, the patient did not show hypertonia in the lower limbs. However, as reported in other patients, this clinical entity may progress from hypotonic to hypertonic status. The most recent neurologic evaluation revealed the presence of hypertonia in the left leg, associated with pyramidal signs, suggesting the possibility of future development of a spastic paraparesis, typical of this disease. Here, we report a case of SPG52 associated with posterior perisylvian polymicrogyria, unexplained transitory hyperammonemia, and absence of facial dysmorphisms, which suggest an expansion of the disease phenotype.
  6 in total

Review 1.  Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks.

Authors:  Paulo Victor Sgobbi de Souza; Wladimir Bocca Vieira de Rezende Pinto; Gabriel Novaes de Rezende Batistella; Thiago Bortholin; Acary Souza Bulle Oliveira
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

2.  Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature.

Authors:  Rami Abou Jamra; Orianne Philippe; Annick Raas-Rothschild; Sebastian H Eck; Elisabeth Graf; Rebecca Buchert; Guntram Borck; Arif Ekici; Felix F Brockschmidt; Markus M Nöthen; Arnold Munnich; Tim M Strom; Andre Reis; Laurence Colleaux
Journal:  Am J Hum Genet       Date:  2011-05-27       Impact factor: 11.025

3.  Recessive loss-of-function mutations in AP4S1 cause mild fever-sensitive seizures, developmental delay and spastic paraplegia through loss of AP-4 complex assembly.

Authors:  Katia Hardies; Patrick May; Tania Djémié; Oana Tarta-Arsene; Tine Deconinck; Dana Craiu; Ingo Helbig; Arvid Suls; Rudy Balling; Sarah Weckhuysen; Peter De Jonghe; Jennifer Hirst
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

4.  Identification of mutations in AP4S1/SPG52 through next generation sequencing in three families.

Authors:  A Tessa; R Battini; A Rubegni; E Storti; C Marini; D Galatolo; R Pasquariello; F M Santorelli
Journal:  Eur J Neurol       Date:  2016-07-22       Impact factor: 6.089

5.  Autosomal recessive spastic tetraplegia caused by AP4M1 and AP4B1 gene mutation: expansion of the facial and neuroimaging features.

Authors:  Beyhan Tüysüz; Kaya Bilguvar; Naci Koçer; Cengiz Yalçınkaya; Okay Çağlayan; Ece Gül; Sezgin Sahin; Sinan Çomu; Murat Günel
Journal:  Am J Med Genet A       Date:  2014-04-03       Impact factor: 2.802

Review 6.  Adaptor protein complexes and intracellular transport.

Authors:  Sang Yoon Park; Xiaoli Guo
Journal:  Biosci Rep       Date:  2014-07-29       Impact factor: 3.840

  6 in total
  2 in total

1.  Systematic Analysis of Brain MRI Findings in Adaptor Protein Complex 4-Associated Hereditary Spastic Paraplegia.

Authors:  Darius Ebrahimi-Fakhari; Julian E Alecu; Marvin Ziegler; Gregory Geisel; Catherine Jordan; Angelica D'Amore; Rebecca C Yeh; Shyam K Akula; Afshin Saffari; Sanjay P Prabhu; Mustafa Sahin; Edward Yang
Journal:  Neurology       Date:  2021-09-20       Impact factor: 9.910

2.  Loss of ap4s1 in zebrafish leads to neurodevelopmental defects resembling spastic paraplegia 52.

Authors:  Angelica D'Amore; Alessandra Tessa; Valentina Naef; Maria Teresa Bassi; Andrea Citterio; Romina Romaniello; Gianluca Fichi; Daniele Galatolo; Serena Mero; Roberta Battini; Giulia Bertocci; Jacopo Baldacci; Federico Sicca; Federica Gemignani; Ivana Ricca; Anna Rubegni; Jennifer Hirst; Maria Marchese; Mustafa Sahin; Darius Ebrahimi-Fakhari; Filippo M Santorelli
Journal:  Ann Clin Transl Neurol       Date:  2020-03-25       Impact factor: 4.511

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.